Takung Art Co., Ltd. TKAT Income Statement

Takung art co., ltd. (TKAT)

Income statement / TTM

Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Jun'12	Mar'12
Revenue
Listing fee
284	217	217	2,217	3,907	4,944	6,400	5,243	5,572	7,354	8,867	11,027	10,914	0	0	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Commission
-	0	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Commission
-	-	-	2,361	-	-	-	6,077	6,112	6,647	6,820	5,943	5,416	0	0	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Authorized agent subscription revenue
-	-	-	-0	-	-	-	191	0	83	405	727	1,049	0	0	0	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-
Management fee
450	460	383	469	569	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Online art sales
-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Management fee
-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Management fee
-	-	-	-	-	-	-	-	-	-	-	1,926	1,761	0	0	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Authorized agent subscription revenue
-	0	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-
Online artwork sales
-	0	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Annual fee
-	0	0	-	0	0	0	0	1	1	1	1	1	0	0	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Total revenue
3,173	2,588	1,828	5,056	8,495	10,568	13,560	12,625	12,922	15,474	17,862	19,626	19,143	20,632	17,597	13,849	11,335	7,201	5,417	4,949	4,719	2,435	1,513	0	-	0	0	-	0	-	-
Cost of revenue
1,861	1,694	1,413	1,912	2,578	2,598	2,590	1,918	1,247	1,128	1,121	1,129	1,129	1,036	965	890	805	730	635	535	434	0	0	0	-	-	0	-	0	-	-
Net Sales
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	0
Cost of Goods Sold
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	0
Gross profit
1,311	894	415	3,144	5,916	7,970	10,969	10,706	11,675	14,346	16,740	18,496	18,014	19,596	16,631	12,959	10,530	6,471	4,781	4,414	4,285	0	0	0	-	-	0	0	0	0	0
Operating expenses
General and administrative expenses
4,662	6,855	7,904	9,590	11,324	12,591	12,882	12,546	12,111	9,533	8,780	8,311	7,299	6,204	5,342	4,173	3,078	2,689	2,222	1,934	1,701	0	0	0	-	-	0	-	0	-	-
Selling expenses
301	189	230	685	898	974	1,449	1,301	1,395	1,550	1,578	1,971	2,272	2,404	1,867	1,212	584	0	0	0	-	-	-	-	-	-	-	-	-	-	-
Impairment loss
-	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Impairment loss construction-in-progress
-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Research and development
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	-	0	0
Selling, general, and administrative
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	-	0	0
Total operating expenses
4,963	7,071	8,487	10,628	12,575	13,892	14,332	13,848	13,506	0	0	0	-	-	-	0	-	-	-	-	-	-	-	-	-	0	-	0	-	0	0
Loss from operations
-3,652	-6,176	-8,071	-7,483	-6,658	-5,922	-3,363	-3,141	-1,831	3,261	6,381	8,213	8,442	10,988	9,421	7,573	6,867	2,703	1,597	1,565	1,679	1,360	906	827	-0	-183	0	0	0	0	0
Other income and expenses:
Interest Income (Expense)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	0
Other (expenses) income
-63	-101	-49	196	457	607	728	704	576	542	520	478	416	328	164	64	14	-0	0	0	-	0	-	-	-	-	-	0	-	0	0
Loan interest expense
-	0	0	-	573	649	601	605	600	595	506	352	202	0	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-
Exchange loss
-246	-768	-1,123	-1,971	-1,337	-522	525	2,008	1,136	541	251	-514	-516	-689	-582	-44	-163	0	0	0	-	-	-	-	-	-	-	-	-	-	-
Grant from National Institute of Health
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-
Interest income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-
Interest (expense)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-
Total other loss
-367	-958	-1,442	-2,194	-1,453	-564	652	2,107	1,112	488	265	-389	-302	-424	-417	20	-149	0	0	0	-	-	-	-	-	0	-	0	-	0	0
Other income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-
Other income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	-	-
Loss before income tax expense
-4,019	-7,134	-9,513	-9,677	-8,111	-6,486	-2,711	-1,034	-718	3,749	6,646	7,824	8,140	10,564	9,003	7,594	6,718	2,700	1,600	1,567	1,681	1,109	698	0	-	0	0	-	0	-	-
Income taxes (expense) benefit
73	-81	-706	-913	-479	-736	131	477	342	897	1,369	1,676	1,769	2,178	1,925	1,556	1,282	586	310	314	312	211	142	129	3	-1	0	0	0	0	0
Net loss
-4,092	-7,053	-8,807	-8,764	-7,631	-5,750	-2,842	-1,511	-1,061	2,852	5,277	6,148	6,370	8,385	7,077	6,038	5,436	2,114	1,289	1,253	1,369	1,151	765	699	-3	-184	0	0	0	0	0
Foreign currency translation adjustment
29	196	205	29	17	-66	248	611	763	-402	-703	-959	-1,082	39	6	11	-1	-19	-0	-2	0	0	0	0	-	-	0	-	0	-	-
Comprehensive loss
-4,063	-6,857	-8,602	-8,734	-7,614	-5,817	-2,593	-900	-298	2,450	4,573	5,188	5,288	8,424	7,084	6,049	5,434	2,095	1,288	1,251	1,370	0	0	0	-	-	0	-	0	-	-
Loss per common stock - basic
-0.10	-0.10	-0.10	-0.06	-0.36	-0.26	-0.10	0.04	-0.20	0.00	0.02	0.08	0.16	0.23	0.11	0.10	0.39	0.12	0.01	0.05	-	-	-	-	-	-	-	0.00	-	0.00	0.00
Loss per common stock - diluted
-0.10	-0.10	-0.10	-0.06	-0.36	-0.26	-0.10	0.04	-0.20	0.00	0.02	0.08	0.14	0.22	0.10	0.10	0.38	0.12	0.01	0.05	-	-	-	-	-	-	-	-	-	-	-
Weighted average number of common shares outstanding -basic
11,255	11,255	11,247	11,226	11,226	11,226	11,217	11,204	11,200	11,188	11,188	10,733	10,667	10,632	10,632	10,632	10,127	9,612	9,332	9,332	-	-	-	-	-	-	-	23,040	-	22,744	22,478
Weighted average number of common shares outstanding -diluted
11,255	11,255	11,247	11,226	11,207	11,226	11,217	11,223	10,135	11,248	11,416	11,509	11,412	11,365	11,311	11,147	10,349	9,612	9,332	9,332	-	-	-	-	-	23,079	-	-	-	-	-
Earnings per common share - basic and diluted (in dollars per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.04	0.00	0.00	-	0.00	-	-	-	-	-
Weighted average number of common shares outstanding - basic and diluted (in shares)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	8,339	8,339	209,976	-	-	-	-	-	-	-